![Strontium,5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide,t…](https://static.cymitquimica.com/products/3D/img/JMB71436.png "Click to enlarge")
Strontium,5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide,tetrahydrate
CAS: 934714-36-0
Ref. 3D-JMB71436
| 50mg | To inquire | ||
| 100mg | To inquire |
Product Information
Strontium,5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide,tetrahydrate is a prodrug of strontium that is hydrolyzed by esomeprazole and omeprazole to release the active form. Strontium has been shown to be effective in treatment of bowel disease. Strontium inhibits the production of prostaglandins and leukotrienes, leading to decreased inflammation in the gastrointestinal tract. It also has a therapeutic effect on reflux disease. Strontium can cause drug interactions with other drugs metabolized by cytochrome P450 enzymes (e.g., esomeprazole) or that inhibit gastric acid secretion (e.g., omeprazole).
Chemical properties
Technical inquiry about: 3D-JMB71436 Strontium,5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide,tetrahydrate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
